AstraZeneca CEO Pascal Soriot, during a Feb. 11 earnings call, detailed the drugmaker's plans to double its COVID-19 vaccine manufacturing output, The Wall Street Journal reported.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,